- Teva, Marksans recall popular diabetes med
Two drugmakers, Teva Pharmaceuticals and Marksans Pharma Limited, have voluntarily recalled their versions of metformin, a popular diabetes drug. - FDA asks 5 drugmakers to recall metformin products
The FDA asked five drugmakers to voluntarily recall their metformin products after it found unacceptable levels of a carcinogen in the drug. - Medtronic heart pump recalled again after link to 4 patient deaths
The FDA issued another class 1 recall of Medtronic’s HeartWare HVAD ventricular assist device after discovering a design issue that has caused four patient deaths. - Apotex recalls diabetes drug after FDA alert
Apotex, a drugmaker based in Toronto, is recalling all lots of its metformin extended-release tablets after the FDA said it found unacceptable levels of a carcinogen in the drug. - Medtronic recalls brain surgery device
Medtronic recalled its StealthStation software, which provides images of a patient’s brain to help surgeons navigate surgical tools and implants used during brain surgery, due to inaccuracies caused by minor patient movements which could cause serious or life-threatening patient harm. - Georgia pharma company recalls thyroid drug for super-potency
Alpharetta, Ga.-based Acella Pharmaceuticals recalled 13 lots of NP Thyroid after finding the drug to be super-potent.
More articles on pharmacy:
States sue 26 generic drugmakers, accused of fixing prices since 2016
Virginia pharmacist pleads guilty to federal drug fraud
NIH to fund, conduct 3 end-stage COVID-19 vaccine trials this summer
